使用MedDRA®编码模糊信息的策略和挑战:挪威药物警戒官员的探索。

IF 4 2区 医学 Q1 PHARMACOLOGY & PHARMACY
Tahmineh Garmann, Hilde Samdal, Daniele Sartori, David Jahanlu, Fredrik Andersen, Elena Rocca
{"title":"使用MedDRA®编码模糊信息的策略和挑战:挪威药物警戒官员的探索。","authors":"Tahmineh Garmann, Hilde Samdal, Daniele Sartori, David Jahanlu, Fredrik Andersen, Elena Rocca","doi":"10.1007/s40264-025-01573-2","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The Medical Dictionary for Regulatory Activities (MedDRA<sup>®</sup>) is an international standardized medical terminology used to code various types of medical information, including safety reports of suspected adverse reactions to medicines. Quantitative studies have highlighted varying levels of coding inconsistency across MedDRA<sup>®</sup>-relevant platforms, though the possible grounds of such inconsistency remain unclear.</p><p><strong>Objective: </strong>We explored the reasoning and strategies employed by pharmacovigilance officers when coding selected ambiguous adverse events to MedDRA<sup>®</sup>, categorized the types of coding inconsistencies, and explored sources of the inconsistencies.</p><p><strong>Methods: </strong>Pharmacovigilance officers from the Norwegian public health sector were invited to participate in a survey-based, cross-sectional study followed by focus group interviews. The survey consisted of 11 coding tasks, with varying degrees of ambiguity, purposively sampled from the Norwegian pharmacovigilance registry. Participants selected the appropriate MedDRA<sup>®</sup> terms and graded the difficulty level of each task on a scale from 1 (least difficult) to 4 (most difficult). Terms selected by participants were compared with a Standard Term Selection (STS), agreed upon by the authors in consultation with a MedDRA<sup>®</sup> trainer. Inconsistencies with the STS were classified as omission (missing term), substitution (extra term selected in the presence of an omission), and addition (extra term selected and none omitted). In focus groups, participants discussed challenges in the coding tasks and the strategies they used to overcome them. Interview transcripts were analyzed using thematic analysis.</p><p><strong>Results: </strong>In total, 26 coders (79% of the eligible population) completed the survey. Of the survey answers, 36% were identical to the STS; answers consistent with the STS varied across the specific coding tasks and did not align with the perceived difficulty of the tasks. The most common inconsistency (30% of the survey answers) arose from substituting one of multiple MedDRA<sup>®</sup> terms. Of the survey answers, 18% included omissions without substitutions, and 6% added unnecessary terms to the STS. Eight of the 26 coders (31%) participated in the focus group interviews. Focus group themes revealed that substitutions were explained by difficulties in translating lay language to medical terminology, finding accurate English translations for Norwegian medical terms, and fitting complex descriptions into MedDRA<sup>®</sup> terms. This was explained by themes related to ambiguity-resolution strategies. Themes explaining omissions included strategies for resolving ambiguity, contextual thinking, causal and pharmacological reasoning in the coding process, and information categorization.</p><p><strong>Conclusions: </strong>Tailored training programs and clear institutional guidelines are needed to target the sources of coding inconsistencies suggested by this study.</p>","PeriodicalId":11382,"journal":{"name":"Drug Safety","volume":" ","pages":""},"PeriodicalIF":4.0000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Strategies and Challenges in Coding Ambiguous Information Using MedDRA<sup>®</sup>: An Exploration Among Norwegian Pharmacovigilance Officers.\",\"authors\":\"Tahmineh Garmann, Hilde Samdal, Daniele Sartori, David Jahanlu, Fredrik Andersen, Elena Rocca\",\"doi\":\"10.1007/s40264-025-01573-2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>The Medical Dictionary for Regulatory Activities (MedDRA<sup>®</sup>) is an international standardized medical terminology used to code various types of medical information, including safety reports of suspected adverse reactions to medicines. Quantitative studies have highlighted varying levels of coding inconsistency across MedDRA<sup>®</sup>-relevant platforms, though the possible grounds of such inconsistency remain unclear.</p><p><strong>Objective: </strong>We explored the reasoning and strategies employed by pharmacovigilance officers when coding selected ambiguous adverse events to MedDRA<sup>®</sup>, categorized the types of coding inconsistencies, and explored sources of the inconsistencies.</p><p><strong>Methods: </strong>Pharmacovigilance officers from the Norwegian public health sector were invited to participate in a survey-based, cross-sectional study followed by focus group interviews. The survey consisted of 11 coding tasks, with varying degrees of ambiguity, purposively sampled from the Norwegian pharmacovigilance registry. Participants selected the appropriate MedDRA<sup>®</sup> terms and graded the difficulty level of each task on a scale from 1 (least difficult) to 4 (most difficult). Terms selected by participants were compared with a Standard Term Selection (STS), agreed upon by the authors in consultation with a MedDRA<sup>®</sup> trainer. Inconsistencies with the STS were classified as omission (missing term), substitution (extra term selected in the presence of an omission), and addition (extra term selected and none omitted). In focus groups, participants discussed challenges in the coding tasks and the strategies they used to overcome them. Interview transcripts were analyzed using thematic analysis.</p><p><strong>Results: </strong>In total, 26 coders (79% of the eligible population) completed the survey. Of the survey answers, 36% were identical to the STS; answers consistent with the STS varied across the specific coding tasks and did not align with the perceived difficulty of the tasks. The most common inconsistency (30% of the survey answers) arose from substituting one of multiple MedDRA<sup>®</sup> terms. Of the survey answers, 18% included omissions without substitutions, and 6% added unnecessary terms to the STS. Eight of the 26 coders (31%) participated in the focus group interviews. Focus group themes revealed that substitutions were explained by difficulties in translating lay language to medical terminology, finding accurate English translations for Norwegian medical terms, and fitting complex descriptions into MedDRA<sup>®</sup> terms. This was explained by themes related to ambiguity-resolution strategies. Themes explaining omissions included strategies for resolving ambiguity, contextual thinking, causal and pharmacological reasoning in the coding process, and information categorization.</p><p><strong>Conclusions: </strong>Tailored training programs and clear institutional guidelines are needed to target the sources of coding inconsistencies suggested by this study.</p>\",\"PeriodicalId\":11382,\"journal\":{\"name\":\"Drug Safety\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug Safety\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s40264-025-01573-2\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Safety","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s40264-025-01573-2","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

简介:监管活动医学词典(MedDRA®)是一个国际标准化的医学术语,用于编码各种类型的医学信息,包括药物可疑不良反应的安全报告。定量研究强调了在MedDRA®相关平台上不同程度的编码不一致,尽管这种不一致的可能原因尚不清楚。目的:探讨药物警戒人员在对MedDRA®的模棱两可不良事件进行编码时的推理和策略,对编码不一致的类型进行分类,并探讨不一致的来源。方法:邀请挪威公共卫生部门的药物警戒官员参加一项基于调查的横断面研究,随后进行焦点小组访谈。该调查包括11个编码任务,具有不同程度的模糊性,有目的地从挪威药物警戒登记处抽样。参与者选择合适的MedDRA®术语,并将每个任务的难度等级从1(最难)到4(最难)进行分级。参与者选择的术语与标准术语选择(STS)进行比较,标准术语选择由作者与MedDRA®培训师协商后同意。与STS的不一致被分类为遗漏(缺少术语),替代(在遗漏的情况下选择额外的术语)和添加(选择额外的术语而没有遗漏)。在焦点小组中,参与者讨论了编码任务中的挑战以及他们用来克服这些挑战的策略。访谈记录采用主题分析进行分析。结果:总共有26名程序员(占合格人口的79%)完成了调查。在调查的答案中,36%与STS相同;与STS一致的答案在特定的编码任务中有所不同,并且与任务的感知难度不一致。最常见的不一致(30%的调查答案)是由于替换了多个MedDRA®术语中的一个。在调查的答案中,18%的人在没有替代的情况下省略了STS, 6%的人在STS中添加了不必要的术语。26名程序员中有8名(31%)参加了焦点小组访谈。焦点小组的主题显示,替换的原因是在将外行语言翻译为医学术语,为挪威医学术语找到准确的英语翻译以及将复杂的描述适合MedDRA术语方面存在困难。这是通过与解决歧义策略相关的主题来解释的。解释省略的主题包括解决歧义的策略、上下文思维、编码过程中的因果和药理推理以及信息分类。结论:需要有针对性的培训计划和明确的制度指南来针对本研究提出的编码不一致的来源。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Strategies and Challenges in Coding Ambiguous Information Using MedDRA®: An Exploration Among Norwegian Pharmacovigilance Officers.

Introduction: The Medical Dictionary for Regulatory Activities (MedDRA®) is an international standardized medical terminology used to code various types of medical information, including safety reports of suspected adverse reactions to medicines. Quantitative studies have highlighted varying levels of coding inconsistency across MedDRA®-relevant platforms, though the possible grounds of such inconsistency remain unclear.

Objective: We explored the reasoning and strategies employed by pharmacovigilance officers when coding selected ambiguous adverse events to MedDRA®, categorized the types of coding inconsistencies, and explored sources of the inconsistencies.

Methods: Pharmacovigilance officers from the Norwegian public health sector were invited to participate in a survey-based, cross-sectional study followed by focus group interviews. The survey consisted of 11 coding tasks, with varying degrees of ambiguity, purposively sampled from the Norwegian pharmacovigilance registry. Participants selected the appropriate MedDRA® terms and graded the difficulty level of each task on a scale from 1 (least difficult) to 4 (most difficult). Terms selected by participants were compared with a Standard Term Selection (STS), agreed upon by the authors in consultation with a MedDRA® trainer. Inconsistencies with the STS were classified as omission (missing term), substitution (extra term selected in the presence of an omission), and addition (extra term selected and none omitted). In focus groups, participants discussed challenges in the coding tasks and the strategies they used to overcome them. Interview transcripts were analyzed using thematic analysis.

Results: In total, 26 coders (79% of the eligible population) completed the survey. Of the survey answers, 36% were identical to the STS; answers consistent with the STS varied across the specific coding tasks and did not align with the perceived difficulty of the tasks. The most common inconsistency (30% of the survey answers) arose from substituting one of multiple MedDRA® terms. Of the survey answers, 18% included omissions without substitutions, and 6% added unnecessary terms to the STS. Eight of the 26 coders (31%) participated in the focus group interviews. Focus group themes revealed that substitutions were explained by difficulties in translating lay language to medical terminology, finding accurate English translations for Norwegian medical terms, and fitting complex descriptions into MedDRA® terms. This was explained by themes related to ambiguity-resolution strategies. Themes explaining omissions included strategies for resolving ambiguity, contextual thinking, causal and pharmacological reasoning in the coding process, and information categorization.

Conclusions: Tailored training programs and clear institutional guidelines are needed to target the sources of coding inconsistencies suggested by this study.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Drug Safety
Drug Safety 医学-毒理学
CiteScore
7.60
自引率
7.10%
发文量
112
审稿时长
6-12 weeks
期刊介绍: Drug Safety is the official journal of the International Society of Pharmacovigilance. The journal includes: Overviews of contentious or emerging issues. Comprehensive narrative reviews that provide an authoritative source of information on epidemiology, clinical features, prevention and management of adverse effects of individual drugs and drug classes. In-depth benefit-risk assessment of adverse effect and efficacy data for a drug in a defined therapeutic area. Systematic reviews (with or without meta-analyses) that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement. Original research articles reporting the results of well-designed studies in disciplines such as pharmacoepidemiology, pharmacovigilance, pharmacology and toxicology, and pharmacogenomics. Editorials and commentaries on topical issues. Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Drug Safety Drugs may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信